86 related articles for article (PubMed ID: 16166309)
1. In vivo assessment of RAS-dependent maintenance of tumor angiogenesis by real-time magnetic resonance imaging.
Tang Y; Kim M; Carrasco D; Kung AL; Chin L; Weissleder R
Cancer Res; 2005 Sep; 65(18):8324-30. PubMed ID: 16166309
[TBL] [Abstract][Full Text] [Related]
2. Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background.
Ackermann J; Frutschi M; Kaloulis K; McKee T; Trumpp A; Beermann F
Cancer Res; 2005 May; 65(10):4005-11. PubMed ID: 15899789
[TBL] [Abstract][Full Text] [Related]
3. Tumor-initiated inflammation overrides protective adaptive immunity in an induced melanoma model in mice.
Soudja SM; Wehbe M; Mas A; Chasson L; de Tenbossche CP; Huijbers I; Van den Eynde B; Schmitt-Verhulst AM
Cancer Res; 2010 May; 70(9):3515-25. PubMed ID: 20406967
[TBL] [Abstract][Full Text] [Related]
4. Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice.
Floyd HS; Jennings-Gee JE; Kock ND; Miller MS
Mol Carcinog; 2006 Jul; 45(7):506-17. PubMed ID: 16482519
[TBL] [Abstract][Full Text] [Related]
5. Essential role for oncogenic Ras in tumour maintenance.
Chin L; Tam A; Pomerantz J; Wong M; Holash J; Bardeesy N; Shen Q; O'Hagan R; Pantginis J; Zhou H; Horner JW; Cordon-Cardo C; Yancopoulos GD; DePinho RA
Nature; 1999 Jul; 400(6743):468-72. PubMed ID: 10440378
[TBL] [Abstract][Full Text] [Related]
6. An inducible mouse model of melanoma expressing a defined tumor antigen.
Huijbers IJ; Krimpenfort P; Chomez P; van der Valk MA; Song JY; Inderberg-Suso EM; Schmitt-Verhulst AM; Berns A; Van den Eynde BJ
Cancer Res; 2006 Mar; 66(6):3278-86. PubMed ID: 16540681
[TBL] [Abstract][Full Text] [Related]
7. R-Ras is a global regulator of vascular regeneration that suppresses intimal hyperplasia and tumor angiogenesis.
Komatsu M; Ruoslahti E
Nat Med; 2005 Dec; 11(12):1346-50. PubMed ID: 16286923
[TBL] [Abstract][Full Text] [Related]
8. A new mechanism of release from senescence: suppression of p16INK4a by beta-catenin.
Curley DP; Bosenberg MW
Pigment Cell Melanoma Res; 2008 Feb; 21(1):5-6. PubMed ID: 18353136
[No Abstract] [Full Text] [Related]
9. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide SNP analysis of Tg.AC transgenic mice reveals an oncogenic collaboration between v-Ha-ras and Ink4a, which is absent in p53 deficiency.
Leder A; McMenamin J; Zhou F; Moran JL; Beier DR; Leder P
Oncogene; 2008 Apr; 27(17):2456-65. PubMed ID: 17952114
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of new melanoma cell lines from C3H mice induced by ethanol plus ultraviolet radiation.
Strickland FM; Pathak S; Multani AS; Pelley RP; Donawho CK
Cancer Res; 2003 Jul; 63(13):3503-10. PubMed ID: 12839934
[TBL] [Abstract][Full Text] [Related]
13. Beta-carotene inhibits tumor-specific angiogenesis by altering the cytokine profile and inhibits the nuclear translocation of transcription factors in B16F-10 melanoma cells.
Guruvayoorappan C; Kuttan G
Integr Cancer Ther; 2007 Sep; 6(3):258-70. PubMed ID: 17761639
[TBL] [Abstract][Full Text] [Related]
14. Induction of nevi and skin tumors in Ink4a/Arf Xpa knockout mice by neonatal, intermittent, or chronic UVB exposures.
van Schanke A; van Venrooij GM; Jongsma MJ; Banus HA; Mullenders LH; van Kranen HJ; de Gruijl FR
Cancer Res; 2006 Mar; 66(5):2608-15. PubMed ID: 16510579
[TBL] [Abstract][Full Text] [Related]
15. Array comparative genome hybridization for tumor classification and gene discovery in mouse models of malignant melanoma.
O'Hagan RC; Brennan CW; Strahs A; Zhang X; Kannan K; Donovan M; Cauwels C; Sharpless NE; Wong WH; Chin L
Cancer Res; 2003 Sep; 63(17):5352-6. PubMed ID: 14500367
[TBL] [Abstract][Full Text] [Related]
16. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
[TBL] [Abstract][Full Text] [Related]
17. N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation.
Shen S; Passioura T; Symonds G; Dolnikov A
Exp Hematol; 2007 Jun; 35(6):908-19. PubMed ID: 17533045
[TBL] [Abstract][Full Text] [Related]
18. Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization.
LaMontagne K; Littlewood-Evans A; Schnell C; O'Reilly T; Wyder L; Sanchez T; Probst B; Butler J; Wood A; Liau G; Billy E; Theuer A; Hla T; Wood J
Cancer Res; 2006 Jan; 66(1):221-31. PubMed ID: 16397235
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance visualization of tumor angiogenesis by targeting neural cell adhesion molecules with the highly sensitive gadolinium-loaded apoferritin probe.
Geninatti Crich S; Bussolati B; Tei L; Grange C; Esposito G; Lanzardo S; Camussi G; Aime S
Cancer Res; 2006 Sep; 66(18):9196-201. PubMed ID: 16982763
[TBL] [Abstract][Full Text] [Related]
20. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
